Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101591250A details a streamlined one-step Mannich synthesis and tartaric acid resolution for high-purity chiral amino alcohol ligands, offering significant cost and supply chain advantages.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel synthesis of Remdesivir intermediates via CN113214320A offers high purity and scalable manufacturing. Discover cost-effective supply chain solutions for antiviral API production.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Advanced synthesis of spiro quaternary ammonium salts via kinetic resolution. Offers superior enantioselectivity for amino acid synthesis with scalable industrial processes.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN110885315A details a high-yield synthesis of (R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one using early-stage resolution for superior purity and cost efficiency.
Patent CN109761984B reveals a novel asymmetric hydrogen transfer method for high-purity chiral purine nucleosides, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN110452150B details a mild, one-step synthesis of axial chiral indole-naphthalenes with high enantioselectivity, offering cost-effective solutions for chiral catalyst manufacturing.
Patent CN108409615B reveals a scalable method for enantiopure tert-butyl sulfinamide. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this novel route.
Patent CN112939841B enables low-cost synthesis of chiral amino acid intermediates without palladium catalysts, ensuring scalable supply chain reliability.
Patent CN119060059B details a novel three-step synthesis for Ritlecitinib Tosylate offering enhanced purity and scalable manufacturing efficiency for global pharmaceutical supply chains.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Patent CN112430235B details a cost-effective synthesis of PF-06651600 intermediate using mild hydrogenation and chiral resolution for scalable pharmaceutical manufacturing.
Novel organocatalytic method for high-purity axial chiral indole-naphthalenes. Efficient scale-up and cost-effective production for asymmetric catalysis applications.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Novel 5-step synthesis reduces corrosion and waste. Ideal for high-purity pharmaceutical intermediate supply chains seeking cost efficiency.
Patent CN110452150B details a novel one-step synthesis of axial chiral indole-naphthalenes using chiral phosphoric acid, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.